Reversing FXa inhibitor activity in patients with acute major bleeding
May
22

Reversing FXa inhibitor activity in patients with acute major bleeding

 May 22, 2023 

Online


Every day, patients are hospitalized with a factor Xa (FXa) inhibitor-related acute major bleed. For those patients, every moment matters. Uncover the latest information on managing patients with FXa inhibitor-related acute major bleeding in this live discussion.

Learning Points:

  • The burden of life-threatening bleeds related to FXa Inhibitors
  • The rationale behind the reversal of anti-FXa activity
  • Clinical trials evaluating the efficacy and safety of FXa inhibitor reversal
  • Real world studies evaluating FXa inhibitor reversals 

Read on go.beckershospitalreview.com

Continue reading at

Interested in this event?


Next Event

  • May
    22

    Psychiatry Conferences

     May 22 to May 23, 2023 

    Berlin, Germany

    Psychiatry Conferences

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Foundation, Inc. All Rights Reserved.

Built on Nov 21, 2024 at 12:56pm